The global Cyberknife Technology Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 5.2% during the forecast period.
Global Cyberknife Technology Market Overview:
Cyberknife is a stereotactic radiosurgery (SRS) system. It is a non-invasive treatment for cancerous and non-cancerous tumours and other conditions where radiation therapy is indicated. It is used to treat conditions throughout the body, including the prostate, lung, brain, spine, head and neck, liver, pancreas, and kidney, and can be an alternative to surgery or for patients who have inoperable or surgically complex tumours.
Global Cyberknife Technology Market Dynamics:
Increasing demand for minimally invasive and technologically advanced procedures are the main factors driving the market growth.
Cyberknife procedure provides a high degree of precision, as it is possible to deliver a very high dose of radiation to the target with minimal damage to the normal tissues and structures surrounding the tumour boosts the market growth. This treatment is based on the principle of destruction of cancerous cells by distracting their DNA by radiation, which helps to slow the growth of cancerous cells. Other factor associated with Cyberknife such as less treatment time also contributes to the market growth. The global Cyberknife technology market is driven by the increase in the global cancer population, diagnosis and treatment rate of cancer-affected population, and medical infrastructure. A study published in the journal Neurosurgery (2017) revealed that Cyberknife technology offers ever-lasting relief from pain to trigeminal neurologia victims. However, the high cost associated with treatment with Cyberknife is the major restraint for the market growth.
The report has profiled key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing RD activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.
Global Cyberknife Technology Market Segment Analysis:
The Global Cyberknife Technology Market is segmented on the basis of Application and End-Users.
Based on the Application, Cyberknife technology is mainly used in the treatment of prostate cancer. Cyberknife can be used as a first-line treatment for early-stage prostate cancer. It can be combined with hormone therapy for cancer that has spread into nearby tissues. It can also be used to slow progression in advanced cancer or cancer that has recurred after previous treatment.
Global Cyberknife Technology Market
To know about the Research Methodology :- Request Free Sample Report
Global Cyberknife Technology Market Regional Insights:
Global Cyberknife Technology Market 1
North America and Europe are projected to dominate the global Cyberknife market during forecast period.
The market in these regions is expected to witness lucrative growth due to the increase in geriatric population, prevalence of chronic diseases and growing demand for less time consuming treatments, increase in the incidence of cancer, and a shift towards painless and non-invasive surgeries. As owing to the large patient population pool in the countries such as China and India, cyberknife market is projected to grow in the forecast period.
Asia Pacific is expected to grow at a faster pace during forecast years.
Owing to the large cancer patient population, rise in the incidence of cancer, and technological advancements, the APAC region is expected to grow at a higher rate. An increase in initiatives undertaken by governments to raise awareness about treatment options, growth in demand for sophisticated therapies and the increasing prevalence of cancer are some of the key factors responsible for the growth of the market for Cyber knife in APAC.
The report also helps in understanding Global Cyberknife Technology Market dynamics, structure by analyzing the market segments and project the Global Cyberknife Technology Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Cyberknife Technology Market make the report investor’s guide.
Global Cyberknife Technology Market, Key Developments:
On June 26, 2020 Accuray Incorporated launched the CyberKnife S7 System, which is an innovative device combining speed, advanced precision and real-time artificial intelligence (AI)-driven motion tracking and synchronization treatment delivery for all stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatment in less than 15 minutes. The CyberKnife S7 System is the next-generation CyberKnife platform, a robotic, non-invasive radiation therapy device capable of treating cancerous and benign tumours throughout the body, as well as neurologic disorders.
Global Cyberknife Technology Market Scope:
Inquire before buying
Global Cyberknife Technology Market 2
Global Cyberknife Technology Market, by Region:
• North America
• South America
Global Cyberknife Technology Market, Key players:
• Accuray Incorporated
• Elekta AB
• Nucletron B.V.
• GE Healthcare
• Hitachi America
• IBA Group
• Mitsubishi Electric
• Sumitomo Heavy Industries
• Varian Medical Systems
• Modus Medical Devices Inc.
• Varian Medical Systems International AG
• Koninklijke Philips N.V.
• Toshiba Medical Systems Corporation
• Shenzhen GeneMDx Biotech. Co., Ltd.